Skip to main content

Advertisement

SpringerLink
Log in

Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Survivin, an important inhibitor of apoptosis, has been found to play an important role in the initiation, progression, and chemoradioresistance of human malignancies. Previously, we have reported that upregulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. The aim of this study was to assess prognostic significance of survivin protein expression in RCC and analyze its correlation with radiosensitivity of RCC cells. RT-PCR and Western blot assays were performed to detect survivin mRNA and protein expression in normal human kidney epithelial cell line (HKEC) or RCC cell lines. The expression of survivin mRNA in RCC and corresponding nontumor kidney tissues was also detected by RT-PCR. Immunohistochemistry was performed to determine survivin protein expression in 75 cases of RCC tissue samples. Moreover, the association of survivin protein expression with clinicopathogical factors and prognosis of RCC patients was statistically analyzed. Small interfering RNA was used to knockdown the endogenous survivin expression in RCC cell line (ACHN) and evaluate the effects of survivin knockdown on proliferation, apoptosis, and radiosensitivity of RCC cell line. RCC cells showed sufficient expression of survivin mRNA and protein, but the expression of survivin gene was not detected in normal HKEC. Moreover, the expression level of survivin mRNA in RCC tissues was significantly higher than that in corresponding nontumor kidney tissues. The immunostaining of survivin protein was mainly located in cytoplasm of RCC tumor cells. Tumor pathological stage (P = 0.028), grade (P = 0.004), and lymph node metastasis (P = 0.017) of RCC patients were significantly correlated with survivin protein expression. In addition, patients with high survivin levels had a significantly shorter overall survival than those with low levels (P < 0.001), and the expression of survivin protein was an independent prognostic factor for RCC patients (P = 0.008). The expression of survivin gene could be reduced in RCC cell line and survivin knockdown could inhibit growth and enhance in vivo radiosensitivity of RCC cell line by inducing apoptosis enhancement. Taken together, the status of survivin protein expression may be an independent factor for predicting the prognosis of RCC patients and tumor-specific survivin knockdown combined with radiotherapy will be a potential strategy for RCC therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Buzaid AC, Todd MB (1989) Therapeutic options in renal cell carcinoma. Semin Oncol 16(Suppl 6):12–16

    CAS  PubMed  Google Scholar 

  3. Altieri DC (2003) Survivin, versatilemodulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589

    Article  CAS  PubMed  Google Scholar 

  4. Chau GY, Lee AF, Tsay SH et al (2007) Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Histopathology 51:204–218

    Article  PubMed  Google Scholar 

  5. Chen WC, Liu Q, Fu JX et al (2004) Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 10:2886–2889

    CAS  PubMed  Google Scholar 

  6. Falleni M, Pellegrini C, Marchetti A et al (2003) Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 200:620–626

    Article  CAS  PubMed  Google Scholar 

  7. Sarela AI, Verbeke CS, Ramsdale J et al (2002) Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 86:886–892

    Article  CAS  PubMed  Google Scholar 

  8. Osaka E, Suzuki T, Osaka S et al (2006) Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem 39:95–100

    Article  CAS  PubMed  Google Scholar 

  9. Asanuma K, Kobayashi D, Furuya D et al (2002) A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 93:1057–1062

    CAS  PubMed  Google Scholar 

  10. Rödel F, Hoffmann J, Distel L et al (2005) Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65:4881–4887

    Article  PubMed  Google Scholar 

  11. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865–875

    Article  CAS  PubMed  Google Scholar 

  12. La Casse EC, Baird S, Korneluk RG et al (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247–3259

    Article  Google Scholar 

  13. Deveraux QL, Takahashi R, Salvesen GS et al (1997) X-linked IAP is a direct inhibitor of cell death proteases. Nature 388:300–304

    Article  CAS  PubMed  Google Scholar 

  14. Deveraux QL, Reed JC (1999) IAP family proteins: suppressors of apoptosis. Genes Dev 13:239–252

    Article  CAS  PubMed  Google Scholar 

  15. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921

    Article  CAS  PubMed  Google Scholar 

  16. Johnson ME, Howerth EW (2004) Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41:599–607

    Article  CAS  PubMed  Google Scholar 

  17. Nouraee N, Mowla SJ, Ozhand A et al (2009) Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Urol J 6:101–108

    PubMed  Google Scholar 

  18. Fields AC, Cotsonis G, Sexton D et al (2004) Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol 17:1378–1385

    Article  CAS  PubMed  Google Scholar 

  19. Cohen C, Lohmann CM, Cotsonis G et al (2003) Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod Pathol 16:574–583

    Article  PubMed  Google Scholar 

  20. Song KY, Jung CK, Park WS et al (2009) Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn J Clin Oncol 39:290–296

    Article  PubMed  Google Scholar 

  21. Troeger A, Siepermann M, Escherich G et al (2007) Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 92:1043–1050

    Article  CAS  PubMed  Google Scholar 

  22. Adida C, Recher C, Raffoux E et al (2000) Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111:196–203

    Article  CAS  PubMed  Google Scholar 

  23. Virrey JJ, Guan S, Li W et al (2008) Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol 173:575–585

    Article  CAS  PubMed  Google Scholar 

  24. Yuan QZ, Wang CT, Mao YQ et al (2010) Enhanced tumor radiosensitivity by a survivin dominant-negative mutant. Oncol Rep 23:97–103

    PubMed  Google Scholar 

  25. Zaffaroni N, Daidone MG (2002) Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist Updat 5:65–72

    Article  CAS  PubMed  Google Scholar 

  26. Ryan BM, O’Donovan N, Duffy MJ (2009) Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 35:553–562

    Article  CAS  PubMed  Google Scholar 

  27. Kami K, Doi R, Koizumi M et al (2005) Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138:299–305

    Article  PubMed  Google Scholar 

  28. Shen J, Liu J, Long Y et al (2009) Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity. Acta Biochim Biophys Sin 41:223–230

    Article  CAS  PubMed  Google Scholar 

  29. Sato A, Ito K, Asano T et al (2007) Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake. Int J Oncol 30:670–695

    Google Scholar 

  30. Song X, Wang JB, Yin DL et al (2009) Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma. Chin Med J 122:2636–2642

    CAS  PubMed  Google Scholar 

  31. Fulda S, Debatin KM (2004) Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64:337–346

    Article  CAS  PubMed  Google Scholar 

  32. Zamparese R, Pannone G, Santoro A et al (2008) Survivin expression in renal cell carcinoma. Cancer Invest 26:929–935

    Article  CAS  PubMed  Google Scholar 

  33. Byun SS, Yeo WG, Lee SE et al (2007) Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Urology 69(1):34–37

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank the Members of Department of Pathology in Xijing Hospital for their sincere help and technical support.

Author information

Authors and Affiliations

  1. Department of Urology, Xi Jing Hospital, Fourth Military Medical University, No. 321 Changle Road, Xi’an, 710032, People’s Republic of China

    Yu Lei, Zhang Geng, Wu Guo-Jun, Wang He & Yuan Jian-Lin

Authors
  1. Yu Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhang Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wu Guo-Jun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuan Jian-Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuan Jian-Lin.

Additional information

Yu Lei and Zhang Geng are contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lei, Y., Geng, Z., Guo-Jun, W. et al. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance. Mol Cell Biochem 344, 23–31 (2010). https://doi.org/10.1007/s11010-010-0525-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0525-3

Keywords

Search

Navigation